Navigating the New Age of Type 2 Diabetes and Obesity Management

The mounting popularity of GLP-1 therapies is changing how people—and the healthcare system—address type 2 diabetes and obesity care. We'll explore the opportunities and risks of these therapies and examine the role of these medications in the long-term management of two of the costliest conditions organizations face.